Biotech

All Articles

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its own various sclerosis (MS) med tolebrutinib to the FDA, ...

Galapagos' stock up as fund reveals intent to form its evolution

.Galapagos is actually happening under additional pressure from entrepreneurs. Having built a 9.9% c...

Cell- focused Sana scoops very first CSO-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of notable management hirings, shootings as well...

Allist pays Jacobio $21M, landing duty in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has gotten itself a starring role in China's KRAS market, paying ou...

ReNeuron leaving purpose substitution after overlooking fundraising goal

.ReNeuron has participated in the long list of biotechs to leave behind Greater london's purpose sto...

MBX declare IPO to take opposition to Ascendis right into period 3

.MBX Biosciences has actually contributed to the recent outbreak of IPO filings. The biotech, which ...

FDA broadens probing into Lykos' MDMA trials: WSJ

.For Lykos Therapies and the business's potential MDMA-assisted treatment for trauma (POST-TRAUMATIC...

Gene publisher Volume laying off 131 employees

.Just times after gene publisher Tome Biosciences announced hidden operational slices, a more clear ...

Repare lays off 25% of staff as biotech halts preclinical R&ampD

.Repare Rehab is actually giving up a fourth of its own workforce as the oncology biotech lessen its...

J &amp J declare FDA confirmation of $6.5 B autoimmune medicine

.Johnson &amp Johnson has gotten another step towards understanding a gain on its $6.5 billion nipoc...